CCL2 and peripheral neuropathy: Paclitaxel increases IL-6, TNF-α, and CCL2 production in dorsal root ganglia neurons (87), and IL-6 neutralizing antibody pretreatment prevents peripheral neuropathy development (88), suggesting the role of increased inflammation in peripheral neuropathy development.